MedPath

Counseling Intervention in Hereditary Hemorrhagic Telangiectasia in the COVID Era.

Not Applicable
Completed
Conditions
Hereditary Hemorrhagic Telangiectasia
Interventions
Other: Counseling
Registration Number
NCT05752253
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

The goal of this interventional study is to determine the incidence of depression, anxiety, sleep disturbances and resilience in a sample of subjects affected by Hereditary Hemorrhagic Telangiectasia. The study is declined through the evaluation of some outcome parameters at the time of enrollment (T0), during the counseling intervention (T1 and T2) and at the end (T3) of the subjects who will have carried out an individual counseling intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria

Recruited subjects have a diagnosis of Hereditary Hemorrhagic Telangiectasia and are 18 years of age or older.

Exclusion Criteria

Previous or current intellectual disability and a diagnosis of psychiatric disorders in accordance with the Diagnostic and Statistical Manual of Mental Disorders, DSM-5.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Patients with Hereditary Hemorragic TeleangectasiaCounselingPatients with Hereditary Hemorragic Teleangectasia
Primary Outcome Measures
NameTimeMethod
Connor-Davidson Resilience Scale (CD-RISC)12 months

Administration of psychometric scales

Hospital Anxiety and Depression Scale (HADS)12 months

Administration of psychometric scales

Pittsburgh Sleep Quality Index (PSQI);12 months

Administration of psychometric scales

Secondary Outcome Measures
NameTimeMethod
Impact of counseling on clients affected by rare diseases12 months

Administration of psychometric scales

Trial Locations

Locations (1)

Fondazione Policlinico Gemelli IRCCS

🇮🇹

Rome, Italy

© Copyright 2025. All Rights Reserved by MedPath